U. of Iowa Settles Arthritis-Patent Lawsuit With Abbott Laboratories

While Abbott Laboratories still plans to appeal a record-setting patent-infringement judgment involving its arthritis drug Humira that could yield millions of dollars to New York University, the company announced this week that it had settled another case related to the drug that was filed by the University of Iowa and its research foundation. The amount and terms of the settlement in that case, filed in June, were not made public.